Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocksADVENZYMES
resources
ADVENZYMES

Advanced Enzyme Technologies Ltd.

NSE: ADVENZYMES
BSE: 540025
Sector: Healthcare
Industry: Biotechnology
321.80+3.2 (+1.00%)
9 Jul, 11:29 AM

Annual Reports and Financial Documents

Advanced Enzyme Technologies Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

Corporate Announcements and Regulatory Filings

Advanced Enzyme Technologies Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  • General8 Jul 2026
    Copy Of Letter Sent To The Shareholders Pursuant To Regulation 36(1)(B) Of SEBI (LODR) Regulations, 2015
    Copy of letter to Shareholders - Pursuant to Regulation 36(1)(b) of SEBI (LODR) Regulations, 2015
  • Business Responsibility and Sustainability Reporting (BRSR)8 Jul 2026
    Business Responsibility and Sustainability Reporting (BRSR)
    Business Responsibility and Sustainability Report for the financial year 2025-2026
  • Reg. 34 (1) Annual Report8 Jul 2026
    Reg. 34 (1) Annual Report.
    Integrated Annual Report for FY 2025-2026
  • AGM8 Jul 2026
    Notice Of The 37Th Annual General Meeting Of The Company
    Notice convening 37th Annual General Meeting of the Company scheduled to be held on Friday, July 31, 2026 at 10.00 a.m. (IST) through Video Conference or Other Audio Visual Means
  • Newspaper Publication4 Jul 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Please find enclosed herewith copy of newspaper advertisement informing the shareholders about the 37th Annual General Meeting of the Company.
  • AGM3 Jul 2026
    Intimation Of The Date Of 37Th Annual General Meeting
    Please find enclosed herewith the intimation regarding the date of the 37th Annual general Meeting.
  • Record Date3 Jul 2026
    Record Date For Payment Of Final Dividend
    Please find enclosed herewith the intimation of record date for payment of final dividend.
  • Closure of Trading Window25 Jun 2026
    Closure of Trading Window
    Please find enclosed herewith the intimation regarding closure of trading window with effect from July 01, 2026.
  • Newspaper Publication12 Jun 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper Publication - Notice to Equity Shareholders of the Company regarding transfer of shares to the Investor Education and Protection Fund (IEPF) and Unclaimed Dividend thereto / Second ....
  • Change in Directorate11 Jun 2026
    Announcement under Regulation 30 (LODR)-Change in Directorate
    Please find enclosed herewith intimation regarding completion of second term of Ms. Rajshree Patel as Independent Director of the Company.
  • Acquisition6 Jun 2026
    Announcement under Regulation 30 (LODR)-Updates on Acquisition
    Please find enclosed herewith the update regarding the additional investment in wholly owned subsidiary of the Company - Advanced Nutrazyme Private Limited.
  • Reg.24(A)-Annual Secretarial Compliance20 May 2026
    Compliances-Reg.24(A)-Annual Secretarial Compliance
    Please find enclosed herewith the Annual Secretarial Compliance Report for year ended March 31, 2026.
  • Analyst / Investor Meet12 May 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
    Please find enclosed herewith audio recording of earnings call held on May 12, 2026.
  • Newspaper Publication11 May 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Please find enclosed herewith copy of newspaper publication of extract of audited consolidated financial results for quarter and year ended March 31, 2026.
  • Press Release / Media Release9 May 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Quarterly Earnings Release dated May 09, 2026
  • Allotment of ESOP / ESPS9 May 2026
    Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
    Allotment of 49,350 Equity Shares of face value of Rs. 2/- per share pursuant to the Exercise of Options under Advanced Enzyme Technologies Limited - Employees Stock Options Scheme 2022.
  • Appointment of Statutory Auditor/s9 May 2026
    Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
    Re-appintment of M S K A & Associates LLP, Chartered Accountants as the Statutory Auditors of the Company for a second term of five consecutive years from the conclusion of the 37th Annual ....
  • Change in Directorate9 May 2026
    Announcement under Regulation 30 (LODR)-Change in Directorate
    Re-appointment of Mr. Mukund Madhusudan Kabra (DIN: 00148294) as Whole Time Director of the Company for another term of 5 years effective from April 01, 2027, subject to the approval of ....
  • Cancellation of Dividend9 May 2026
    Announcement under Regulation 30 (LODR)-Cancellation of Dividend
    The Board Members in meeting held today has decided to defer the declaration of an Interim Dividend. While the Company continues to maintain health financial position and robust liquidity, ....
  • Dividend9 May 2026
    Corporate Action-Board approves Dividend
    Recommended a Final Dividend - 67.5% i.e. Rs. 1.35/- per Equity Share on the face value of Rs. 2 each for the Financial Year 2025-26, Subject to the approval of the Shareholders at the ....

Frequently Asked Questions

Where can I download the annual report of Advanced Enzyme Technologies Ltd.?
Annual reports of Advanced Enzyme Technologies Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Advanced Enzyme Technologies Ltd.?
Quarterly earnings results and presentations of Advanced Enzyme Technologies Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Advanced Enzyme Technologies Ltd. publish earnings call transcripts?
Earnings call transcripts of Advanced Enzyme Technologies Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Advanced Enzyme Technologies Ltd.?
Investor presentations and annual day presentations of Advanced Enzyme Technologies Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Advanced Enzyme Technologies Ltd.?
Corporate announcements and regulatory filings of Advanced Enzyme Technologies Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Advanced Enzyme Technologies Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Advanced Enzyme Technologies Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Advanced Enzyme Technologies Ltd.?
The ISIN (International Securities Identification Number) of Advanced Enzyme Technologies Ltd. is INE837H01020. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Advanced Enzyme Technologies Ltd. listed?
Advanced Enzyme Technologies Ltd. is listed on NSE and BSE. The NSE symbol is ADVENZYMES and the BSE code is -.
Where can I find the shareholding pattern of Advanced Enzyme Technologies Ltd.?
The quarterly shareholding pattern of Advanced Enzyme Technologies Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Advanced Enzyme Technologies Ltd. on Sharpely?
Share price data for Advanced Enzyme Technologies Ltd. is updated as of 9 Jul 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.